Find what matters to you

From the continuous development of clinical trial and data platforms to the ever-increasing complexity of therapeutic landscapes, understanding the best approach towards conducting feasibility for a clinical trial can prove daunting. Through our expertise in the most innovative feasibility tools and data platforms, we combine these data sources with our operational experience to put forth the most comprehensive, data-driven approaches to starting clinical studies off on the right foot.

A very common yet very critical question for a 505(b)(2) development program is “What clinical studies are needed to support the marketing application?” The clinical program required is very dependent upon the specifics of the new drug product and indication, and the studies necessary to gain approval can range from a single bioequivalence study to a more comprehensive Phase 2 and Phase 3 clinical program.